Correlation Between Citius Pharmaceuticals and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both Citius Pharmaceuticals and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citius Pharmaceuticals and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citius Pharmaceuticals and Leap Therapeutics, you can compare the effects of market volatilities on Citius Pharmaceuticals and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citius Pharmaceuticals with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citius Pharmaceuticals and Leap Therapeutics.
Diversification Opportunities for Citius Pharmaceuticals and Leap Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Citius and Leap is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Citius Pharmaceuticals and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Citius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citius Pharmaceuticals are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Citius Pharmaceuticals i.e., Citius Pharmaceuticals and Leap Therapeutics go up and down completely randomly.
Pair Corralation between Citius Pharmaceuticals and Leap Therapeutics
Given the investment horizon of 90 days Citius Pharmaceuticals is expected to under-perform the Leap Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Citius Pharmaceuticals is 7.75 times less risky than Leap Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Leap Therapeutics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 29.00 in Leap Therapeutics on August 18, 2025 and sell it today you would earn a total of 176.00 from holding Leap Therapeutics or generate 606.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 96.92% |
| Values | Daily Returns |
Citius Pharmaceuticals vs. Leap Therapeutics
Performance |
| Timeline |
| Citius Pharmaceuticals |
| Leap Therapeutics |
Citius Pharmaceuticals and Leap Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citius Pharmaceuticals and Leap Therapeutics
The main advantage of trading using opposite Citius Pharmaceuticals and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citius Pharmaceuticals position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.| Citius Pharmaceuticals vs. Athira Pharma | Citius Pharmaceuticals vs. Leap Therapeutics | Citius Pharmaceuticals vs. LMF Acquisition Opportunities | Citius Pharmaceuticals vs. Apollomics Class A |
| Leap Therapeutics vs. Citius Pharmaceuticals | Leap Therapeutics vs. Athira Pharma | Leap Therapeutics vs. Curis Inc | Leap Therapeutics vs. Processa Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |